美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
82182-106-14	82182-106	HUMAN PRESCRIPTION DRUG	Sucralfate	Sucralfate	SUSPENSION	ORAL	20240201	N/A	NDA AUTHORIZED GENERIC	NDA019183	Pacific Pharma, Inc.	SUCRALFATE	1 g/10mL	420 mL in 1 BOTTLE (82182-106-14)
0254-1011-96	0254-1011	HUMAN PRESCRIPTION DRUG	Sucralfate	Sucralfate	SUSPENSION	ORAL	20200127	20250228	NDA AUTHORIZED GENERIC	NDA019183	Par Pharmaceutical Inc.	SUCRALFATE	1 g/10mL	420 mL in 1 BOTTLE (0254-1011-96)
17856-1011-1	17856-1011	HUMAN PRESCRIPTION DRUG	Sucralfate	Sucralfate	SUSPENSION	ORAL	20240418	20250228	NDA AUTHORIZED GENERIC	NDA019183	ATLANTIC BIOLOGICALS CORP.	SUCRALFATE	1 g/10mL	72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-1011-1) / 10 mL in 1 CUP, UNIT-DOSE (17856-1011-2)
58914-170-14	58914-170	HUMAN PRESCRIPTION DRUG	Carafate	Sucralfate	SUSPENSION	ORAL	19931216	N/A	NDA	NDA019183	Allergan, Inc.	SUCRALFATE	1 g/10mL	420 mL in 1 BOTTLE (58914-170-14)
58914-170-60	58914-170	HUMAN PRESCRIPTION DRUG	Carafate	Sucralfate	SUSPENSION	ORAL	19931216	N/A	NDA	NDA019183	Allergan, Inc.	SUCRALFATE	1 g/10mL	6 CUP, UNIT-DOSE in 1 BOX (58914-170-60) / 10 mL in 1 CUP, UNIT-DOSE
68094-043-61	68094-043	HUMAN PRESCRIPTION DRUG	Sucralfate	Sucralfate	SUSPENSION	ORAL	20200319	20250228	NDA AUTHORIZED GENERIC	NDA019183	Precision Dose, Inc.	SUCRALFATE	1 g/10mL	10 TRAY in 1 CASE (68094-043-61) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (68094-043-59)
68094-043-62	68094-043	HUMAN PRESCRIPTION DRUG	Sucralfate	Sucralfate	SUSPENSION	ORAL	20200319	20250228	NDA AUTHORIZED GENERIC	NDA019183	Precision Dose, Inc.	SUCRALFATE	1 g/10mL	3 TRAY in 1 CASE (68094-043-62) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (68094-043-59)